Test Price
2,800 AED✅ Home Collection Available
DNAAF2 Gene Analysis for Primary Ciliary Dyskinesia Type 10 (NGS) in UAE
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity, confirmed by ISO 9001:2015-accredited sequencing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain, VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Support: Post-test telephonic guidance with a DHA-licensed genetic specialist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This Genetic Test screens the entire coding region of the DNAAF2 gene for pathogenic variants, confirming the molecular diagnosis of primary ciliary dyskinesia type 10—a genetically heterogeneous disorder of motile cilia causing chronic sinopulmonary infections, laterality defects, and infertility.
| Parameter | Our Test (DNAAF2 NGS) | Closest Alternative (Nasal NO + EM) |
|---|---|---|
| Methodology | NGS with full gene coverage, validated bioinformatics pipeline | Nasal nitric oxide measurement ± ciliary ultrastructure analysis (electron microscopy) |
| Turnaround Time | 3–4 weeks | 1–3 weeks (but often requires multiple visits and functional assays) |
| Diagnostic Precision | Mutational resolution, identifies carrier status, subtypes disease | Phenotypic screening only; may miss atypical presentations |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) notes: “A confirmed DNAAF2 pathogenic variant provides a definitive molecular diagnosis for primary ciliary dyskinesia type 10 with high analytical validity. However, integrated clinical assessment—including pulmonary function, fertility history, and imaging—remains critical for comprehensive patient management. All patients should continue existing therapies under their physician’s supervision.”
Advisory – Medication Continuation
⚠️ Do not discontinue any prescribed medication without consulting your treating physician. This genetic test is for diagnostic confirmation only and does not replace ongoing clinical care.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a blood or DNA sample; active febrile illness requiring urgent care; minors without legal guardian consent (per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- ER Red Flags: Acute respiratory distress, high fever with sinus pain, sudden hearing loss – seek immediate medical attention.
This test is performed under DHA Facility License Number 1143. All genetic data handled in compliance with UAE PDPL.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the DNAAF2 gene test for primary ciliary dyskinesia type 10?
Our Genetic Test delivers 99.9% diagnostic sensitivity, ensuring reliable detection of pathogenic variants in the gene. The comprehensive analysis uses next-generation sequencing with orthogonal confirmation of all clinically significant findings, providing a molecular diagnosis that meets international guidelines.
2. What is the turnaround time for this genetic test in the UAE?
The test requires 3 to 4 weeks for complete sequencing and clinical interpretation by our genetics experts. This includes DNA extraction, library preparation, high-depth NGS, bioinformatic analysis, and final reporting by DHA-licensed molecular pathologists. Urgent preliminary results are available upon request.
3. Is home collection available for this DNA test?
Yes, we offer paid hospital-grade home collection via ISO-certified cold-chain phlebotomy services across all UAE emirates. Our VIP mobile phlebotomists arrive within 60 minutes in Dubai and Abu Dhabi, equipped with temperature-controlled transport kits and FTA cards for sample stability.
UAE Regulatory & Data Privacy Adherence
- Data Protection: All genetic information is processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient Consent: Informed consent obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Quality Certification: ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | DNAAF2 Gene Analysis for Primary Ciliary Dyskinesia Type 10 (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage and orthogonal confirmation |
| ICD-10-CM Code | Q34.8 |
| LOINC Code | 101034-4 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians